Inside out: regenerative medicine for recessive dystrophic epidermolysis bullosa
Authors:
- 1 November 2017
- journal article
- review article
- Published by Springer Nature in Pediatric Research
- Vol. 83 (1-2) , 318-324
Abstract
Epidermolysis bullosa is classified as a genodermatosis, an inherited genetic skin disorder that results in severe, chronic skin blistering with painful and life-threatening complications. Although there is currently no cure for epidermolysis bullosa, concurrent advances in gene and stem cell therapies are converging toward combinatorial therapies that hold the promise of clinically meaningful and lifelong improvement. Recent studies using hematopoietic stem cells and mesenchymal stromal/stem cells to treat epidermolysis bullosa have demonstrated the potential for sustained, effective management of the most severe cases. Furthermore, advances in the use of gene therapy and gene-editing techniques, coupled with the development of induced pluripotent stem cells from patients with epidermolysis bullosa, allow for autologous therapies derived from a renewable population of cells that are patient-specific. Here we describe emerging treatments for epidermolysis bullosa and other genodermatoses, along with a discussion of their benefits and limitations as effective therapies.Keywords
This publication has 81 references indexed in Scilit:
- Collagen VII plays a dual role in wound healingJournal of Clinical Investigation, 2013
- Global remodelling of cellular microenvironment due to loss of collagen VIIMolecular Systems Biology, 2013
- FLASH assembly of TALENs for high-throughput genome editingNature Biotechnology, 2012
- PDGFRα-positive cells in bone marrow are mobilized by high mobility group box 1 (HMGB1) to regenerate injured epitheliaProceedings of the National Academy of Sciences, 2011
- Bone Marrow Transplantation for Recessive Dystrophic Epidermolysis BullosaNew England Journal of Medicine, 2010
- SIN Retroviral Vectors Expressing COL7A1 Under Human Promoters for Ex Vivo Gene Therapy of Recessive Dystrophic Epidermolysis BullosaMolecular Therapy, 2010
- Type VII Collagen: The Anchoring Fibril Protein at Fault in Dystrophic Epidermolysis BullosaDermatologic Clinics, 2010
- Induced Pluripotent Stem Cell Lines Derived from Human Somatic CellsScience, 2007
- Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined FactorsCell, 2006
- Three clonal types of keratinocyte with different capacities for multiplication.Proceedings of the National Academy of Sciences, 1987